Phase 1 study of MEDI3902, an investigational anti–Pseudomonas aeruginosa PcrV and Psl bispecific human monoclonal antibody, in healthy adults

2018124 citationsJournal Articlebronze Open Access

Authors

Good health and well-being

Published in: Clinical Microbiology and Infection

Volume 25, Issue 5, pp. 629.e1-629.e6

Field-Weighted Citation Impact: 6.10